SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-005062
Filing Date
2014-01-31
Accepted
2014-01-30 17:31:31
Documents
1
Group Members
CASEY M. TANSEYDAVID LIDDLEIRWIN FEDERMANJONATHAN D. ROOTPHILIP M. YOUNGPRESIDIO MANAGEMENT GROUP VIII, L.L.C.STEVEN M. KRAUSZUSVP ENTREPRENEUR PARTNERS VIII-A, L.P.USVP ENTREPRENEUR PARTNERS VIII-B, L.P.USVP VIII AFFILIATES FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G v365951_sc13g.htm SC 13G 180238
  Complete submission text file 0001144204-14-005062.txt   182086
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2735 SAND HILL ROAD MENLO PARK CA 94025 650 854 9080
US VENTURE PARTNERS VIII L P (Filed by) CIK: 0001225444 (see all company filings)

IRS No.: 912090473 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87757 | Film No.: 14561715
SIC: 2834 Pharmaceutical Preparations